BioMedical SIG #4

BioMedical SIG #4

Learn about essential IP strategies for healthcare spin-outs, focusing on how tailored approaches for biotech, pharma, and digital health innovations can ensure long-term success.

Book Your Place

This event has now expired

Fourth webinar in the series: From research and innovation to development: how to plan and execute translational projects in life sciences, this edition looks more closely at IP protection strategies for translational research.

It focuses on intellectual property (IP) and spin-out strategies in the human healthcare sector. A well-designed IP strategy, tailored to the type of innovation, is crucial for the long-term success of university spin-outs.

Join experts Sara Holland, Dave Holt, and Elisabeth Downey as they guide you through the key elements of a comprehensive IP strategy, including licences and agreements. They’ll share insights on the essential components of an IP strategy for the healthcare sector and discuss how these components vary based on the type of innovation—whether in biotech, pharma, or digital health—and the intended business model.

Booking Options

  • Are you an ASTP Member?

  • By proceeding with this booking, you are agreeing to allow ASTP to use your image solely for promotional and educational purposes.

Testimonials

testimonial

The expert-panel discussion educated me in strategic and meritorious choice of inventions to approach investors and manage investment funds for establishing a spin off.  

Ram Siddappa

Erasmus MC, Netherlands

testimonial

ASTP corroborates the strong need for profound insights and exchanges on practices, instruments and competencies that cut across functional, organisational, institutional, sectorial and geographic boundaries.

Koenraad Debackere

KU Leuven, Belgium

testimonial

Most relevant, interesting and practical training I have ever had, very interactive an multi-disciplinary. It makes an IMPACT.

Edith van Lishout

KU Leuven, Belgium

testimonial

This course gives an in-depth understanding on managing contract portfolio, including research contracts, license agreements, and other collaboration agreements.

Ram Siddappa

Erasmus MC, Netherlands

testimonial

A must-do for any staff involved in technology transfer and start-up creation.

Frederic Ratel

Institute of Chemical Research of Catalonia, Spain